Testing cancer risk in unclear thyroid nodules
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at ways to better estimate the cancer risk of thyroid nodules that are “unclear” on standard testing. It uses information from your clinical history, ultrasound findings, and additional lab/genetic-type features to help sort which nodules are more likely to be cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a thyroid nodule labeled Bethesda Class III or Class IV
- You do not have any thyroid nodules labeled Bethesda Class V or VI
- You do not already have signs of lymph node spread in the neck before surgery
- You do not have signs that cancer has spread to distant parts of the body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study looks at how environmental exposures may relate to thyroid cancer. If you have a suspicious thyroid nodule and are planning surgery, your biopsy or surgical tissue may be used to understand risk factors.
This study combines genetic testing and urine protein analysis to help doctors better understand which newly diagnosed thyroid cancers might be more serious and need closer monitoring after treatment. By learning more about your specific cancer, the research aims to improve how doctors care for thyroid cancer patients.
This study uses artificial intelligence (AI) to look at ultrasound images and cell samples from thyroid nodules that had an unclear biopsy result. The goal is to see if AI can better tell which nodules are cancerous, helping avoid unnecessary surgery in the future.
This trial studies a decision-support tool to help people make choices about care for thyroid nodules that look indeterminate to cancer on biopsy. It may help you understand options and decide next steps more confidently.
This study tests a new tool (ThyroidPrint) to see if it can accurately predict whether a thyroid nodule with unclear biopsy results is benign or malignant. The goal is to help doctors and patients decide on surgery more confidently.
Hear when a new Thyroid Nodule trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.